Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Expression, purification, crystallization and X-ray data collection for RAS and its mutants.

Johnson CW, Buhrman G, Ting PY, Colicelli J, Mattos C.

Data Brief. 2015 Dec 17;6:423-7. doi: 10.1016/j.dib.2015.12.007. eCollection 2016 Mar.

2.

The RAB5-GEF Function of RIN1 Regulates Multiple Steps During Listeria monocytogenes Infection.

Balaji K, French CT, Miller JF, Colicelli J.

Traffic. 2015 Jul;16(7):796. doi: 10.1111/tra.12268. Epub 2015 Feb 24. No abstract available.

3.

Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.

Ting PY, Johnson CW, Fang C, Cao X, Graeber TG, Mattos C, Colicelli J.

FASEB J. 2015 Sep;29(9):3750-61. doi: 10.1096/fj.15-271510. Epub 2015 May 21.

4.

Identification of small molecules that disrupt signaling between ABL and its positive regulator RIN1.

Ting PY, Damoiseaux R, Titz B, Bradley KA, Graeber TG, Fernández-Vega V, Bannister TD, Chase P, Nair R, Scampavia L, Hodder P, Spicer TP, Colicelli J.

PLoS One. 2015 Mar 26;10(3):e0121833. doi: 10.1371/journal.pone.0121833. eCollection 2015.

5.

The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infection.

Balaji K, French CT, Miller JF, Colicelli J.

Traffic. 2014 Nov;15(11):1206-18. doi: 10.1111/tra.12204. Epub 2014 Sep 4. Erratum in: Traffic. 2015 Jul;16(7):796.

6.

RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinases.

Balaji K, Colicelli J.

Commun Integr Biol. 2013 Sep 1;6(5):e25421. doi: 10.4161/cib.25421. Epub 2013 Jun 25.

7.

Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.

Gillespie EJ, Ho CL, Balaji K, Clemens DL, Deng G, Wang YE, Elsaesser HJ, Tamilselvam B, Gargi A, Dixon SD, France B, Chamberlain BT, Blanke SR, Cheng G, de la Torre JC, Brooks DG, Jung ME, Colicelli J, Damoiseaux R, Bradley KA.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4904-12. doi: 10.1073/pnas.1302334110. Epub 2013 Nov 4.

8.

RIN3 is a negative regulator of mast cell responses to SCF.

Janson C, Kasahara N, Prendergast GC, Colicelli J.

PLoS One. 2012;7(11):e49615. doi: 10.1371/journal.pone.0049615. Epub 2012 Nov 20.

9.

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR.

Balaji K, Mooser C, Janson CM, Bliss JM, Hojjat H, Colicelli J.

J Cell Sci. 2012 Dec 1;125(Pt 23):5887-96. doi: 10.1242/jcs.113688. Epub 2012 Sep 12.

10.

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.

Thai M, Ting PY, McLaughlin J, Cheng D, Müschen M, Witte ON, Colicelli J.

Leukemia. 2011 Feb;25(2):290-300. doi: 10.1038/leu.2010.268. Epub 2010 Nov 19.

11.

ABL tyrosine kinases: evolution of function, regulation, and specificity.

Colicelli J.

Sci Signal. 2010 Sep 14;3(139):re6. doi: 10.1126/scisignal.3139re6. Review. Erratum in: Sci Signal. 2011 Aug 30;4(188):er4.

12.

Signal transduction: RABGEF1 fingers RAS for ubiquitination.

Colicelli J.

Curr Biol. 2010 Aug 10;20(15):R630-2. doi: 10.1016/j.cub.2010.06.019.

13.

Regulated expression of the Ras effector Rin1 in forebrain neurons.

Dzudzor B, Huynh L, Thai M, Bliss JM, Nagaoka Y, Wang Y, Ch'ng TH, Jiang M, Martin KC, Colicelli J.

Mol Cell Neurosci. 2010 Jan;43(1):108-16. doi: 10.1016/j.mcn.2009.09.012. Epub 2009 Oct 24.

14.

Fear learning and extinction are linked to neuronal plasticity through Rin1 signaling.

Bliss JM, Gray EE, Dhaka A, O'Dell TJ, Colicelli J.

J Neurosci Res. 2010 Mar;88(4):917-26. doi: 10.1002/jnr.22252.

15.

Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.

Cao X, Tanis KQ, Koleske AJ, Colicelli J.

J Biol Chem. 2008 Nov 14;283(46):31401-7. doi: 10.1074/jbc.M804002200. Epub 2008 Sep 16.

16.

The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons.

Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12539-44. doi: 10.1073/pnas.0801174105. Epub 2008 Aug 22.

17.

Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration.

Hu H, Milstein M, Bliss JM, Thai M, Malhotra G, Huynh LC, Colicelli J.

Mol Cell Biol. 2008 Mar;28(5):1573-83. Epub 2007 Dec 26.

18.

RIN1 is a breast tumor suppressor gene.

Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J.

Cancer Res. 2007 Dec 15;67(24):11510-6.

19.

Proteomic identification of the cerebral cavernous malformation signaling complex.

Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, Wu CC.

J Proteome Res. 2007 Nov;6(11):4343-55. Epub 2007 Sep 27.

PMID:
17900104
20.
21.

The RIN family of Ras effectors.

Bliss JM, Venkatesh B, Colicelli J.

Methods Enzymol. 2006;407:335-44.

PMID:
16757336
22.

RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.

Hu H, Bliss JM, Wang Y, Colicelli J.

Curr Biol. 2005 May 10;15(9):815-23.

23.

Human RAS superfamily proteins and related GTPases.

Colicelli J.

Sci STKE. 2004 Sep 7;2004(250):RE13. Review.

24.

The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis.

Huai Q, Colicelli J, Ke H.

Biochemistry. 2003 Nov 18;42(45):13220-6.

PMID:
14609333
25.

The RAS effector RIN1 modulates the formation of aversive memories.

Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, Silva AJ, O'Dell TJ, Colicelli J.

J Neurosci. 2003 Feb 1;23(3):748-57.

26.

The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins.

Wang Y, Waldron RT, Dhaka A, Patel A, Riley MM, Rozengurt E, Colicelli J.

Mol Cell Biol. 2002 Feb;22(3):916-26.

27.

Molecular docking of competitive phosphodiesterase inhibitors.

Dym O, Xenarios I, Ke H, Colicelli J.

Mol Pharmacol. 2002 Jan;61(1):20-5.

28.

RAS interaction with effector target RIN1.

Wang Y, Colicelli J.

Methods Enzymol. 2001;332:139-51. No abstract available.

PMID:
11305092
29.

BCR/ABL inhibition by an escort/phosphatase fusion protein.

Lim YM, Wong S, Lau G, Witte ON, Colicelli J.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12233-8.

30.

A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.

Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM, Park NH, Colicelli J, Gollin SM.

Genes Chromosomes Cancer. 2000 Jun;28(2):153-63.

PMID:
10825000
31.

Human ERK1 induces filamentous growth and cell wall remodeling pathways in Saccharomyces cerevisiae.

Atienza JM, Suh M, Xenarios I, Landgraf R, Colicelli J.

J Biol Chem. 2000 Jul 7;275(27):20638-46.

32.

Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development.

Deng XW, Dubiel W, Wei N, Hofmann K, Mundt K, Colicelli J, Kato J, Naumann M, Segal D, Seeger M, Carr A, Glickman M, Chamovitz DA.

Trends Genet. 2000 May;16(5):202-3. No abstract available. Erratum in: Trends Genet 2000 Jul;16(7):289.

PMID:
10782111
33.

Identification of inhibitor specificity determinants in a mammalian phosphodiesterase.

Atienza JM, Susanto D, Huang C, McCarty AS, Colicelli J.

J Biol Chem. 1999 Feb 19;274(8):4839-47.

34.

Yeast model system for study of mammalian phosphodiesterases.

Atienza JM, Colicelli J.

Methods. 1998 Jan;14(1):35-42.

PMID:
9500856
35.

Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.

Afar DE, Han L, McLaughlin J, Wong S, Dhaka A, Parmar K, Rosenberg N, Witte ON, Colicelli J.

Immunity. 1997 Jun;6(6):773-82.

36.

Protein binding and signaling properties of RIN1 suggest a unique effector function.

Han L, Wong D, Dhaka A, Afar D, White M, Xie W, Herschman H, Witte O, Colicelli J.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):4954-9.

37.

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system.

Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Wälter S, Tait D, Colicelli J, Lehrach H.

Hum Mol Genet. 1997 Mar;6(3):487-95.

PMID:
9147654
38.
39.

Truncated forms of a novel yeast protein suppress the lethality of a G protein alpha subunit deficiency by interacting with the beta subunit.

Spain BH, Koo D, Ramakrishnan M, Dzudzor B, Colicelli J.

J Biol Chem. 1995 Oct 27;270(43):25435-44.

41.

Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase.

Pillai R, Staub SF, Colicelli J.

J Biol Chem. 1994 Dec 2;269(48):30676-81.

43.

Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase.

Pillai R, Kytle K, Reyes A, Colicelli J.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11970-4.

44.
45.

Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae.

Colicelli J, Nicolette C, Birchmeier C, Rodgers L, Riggs M, Wigler M.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2913-7.

46.

Mutational mapping of RAS-responsive domains of the Saccharomyces cerevisiae adenylyl cyclase.

Colicelli J, Field J, Ballester R, Chester N, Young D, Wigler M.

Mol Cell Biol. 1990 Jun;10(6):2539-43.

47.

Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein.

Field J, Vojtek A, Ballester R, Bolger G, Colicelli J, Ferguson K, Gerst J, Kataoka T, Michaeli T, Powers S, et al.

Cell. 1990 Apr 20;61(2):319-27.

PMID:
2184942
48.

Mutations of the adenylyl cyclase gene that block RAS function in Saccharomyces cerevisiae.

Field J, Xu HP, Michaeli T, Ballester R, Sass P, Wigler M, Colicelli J.

Science. 1990 Jan 26;247(4941):464-7.

PMID:
2405488
49.

Isolation and characterization of a mammalian gene encoding a high-affinity cAMP phosphodiesterase.

Colicelli J, Birchmeier C, Michaeli T, O'Neill K, Riggs M, Wigler M.

Proc Natl Acad Sci U S A. 1989 May;86(10):3599-603.

Supplemental Content

Loading ...
Support Center